Literature DB >> 34100001

Convalescent plasma transfusion for pregnant patients with COVID-19.

Antonio Mastroianni1, Sonia Greco1, Maria Vittoria Mauro2, Luciana Chidichimo1, Valeria Vangeli1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34100001      PMCID： PMC8172147          DOI： 10.1016/S2666-5247(21)00130-0

Source DB:  PubMed          Journal:  Lancet Microbe        ISSN： 2666-5247


× No keyword cloud information.
  5 in total

1.  Evaluation of Immunological Parameters in Pregnant Women: Low Levels of B and NK Cells.

Authors:  Juliana Araújo de Carvalho Schettini; Thomás Virgílio Gomes; Claudeir Dias da Silva Júnior; Sandra de Andrade Heráclio; Isabela Cristina Coutinho de Albuquerque Neiva Coelho; Leuridan Cavalcante Torres
Journal:  Rev Bras Ginecol Obstet       Date:  2019-03-25

2.  Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2.

Authors:  Aya Mohr-Sasson; Jennifer Chayo; Yossi Bart; Raanan Meyer; Eyal Sivan; Shali Mazaki-Tovi; Yoav Yinon
Journal:  Arch Gynecol Obstet       Date:  2020-06-22       Impact factor: 2.344

3.  Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.

Authors:  Jennifer Jacobson; Kathleen Antony; Michael Beninati; William Alward; Kara K Hoppe
Journal:  Case Rep Womens Health       Date:  2020-11-25

4.  Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19.

Authors:  Roman N Rodionov; Anne Biener; Peter Spieth; Martin Achleitner; Kristina Hölig; Martin Aringer; Geltrude Mingrone; Victor M Corman; Christian Drosten; Stefan R Bornstein; Torsten Tonn; Martin Kolditz
Journal:  Lancet Microbe       Date:  2021-03-30

Review 5.  Is pregnancy an immunological contributor to severe or controlled COVID-19 disease?

Authors:  Nazeeh Hanna; Monica Hanna; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2020-08-20       Impact factor: 3.777
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.